- Home
- HNST vs LXEO Comparison
HNST vs LXEO Comparison
Compare HNST & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNST
- LXEO
- Stock Information
- Founded
- HNST 2012
- LXEO 2017
- Country
- HNST United States
- LXEO United States
- Employees
- HNST N/A
- LXEO N/A
- Industry
- HNST Catalog/Specialty Distribution
- LXEO
- Sector
- HNST Consumer Discretionary
- LXEO
- Exchange
- HNST Nasdaq
- LXEO Nasdaq
- Market Cap
- HNST 370.3M
- LXEO 314.1M
- IPO Year
- HNST 2021
- LXEO 2023
- Fundamental
- Price
- HNST $6.91
- LXEO $6.65
- Analyst Decision
- HNST Buy
- LXEO Strong Buy
- Analyst Count
- HNST 6
- LXEO 7
- Target Price
- HNST $5.54
- LXEO $22.71
- AVG Volume (30 Days)
- HNST 3.5M
- LXEO 644.2K
- Earning Date
- HNST 11-12-2024
- LXEO 11-13-2024
- Dividend Yield
- HNST N/A
- LXEO N/A
- EPS Growth
- HNST N/A
- LXEO N/A
- EPS
- HNST N/A
- LXEO N/A
- Revenue
- HNST $368,767,000.00
- LXEO N/A
- Revenue This Year
- HNST $9.14
- LXEO N/A
- Revenue Next Year
- HNST $4.94
- LXEO N/A
- P/E Ratio
- HNST N/A
- LXEO N/A
- Revenue Growth
- HNST 9.77
- LXEO N/A
- 52 Week Low
- HNST $1.41
- LXEO $6.65
- 52 Week High
- HNST $7.14
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- HNST 89.44
- LXEO 30.96
- Support Level
- HNST $3.73
- LXEO $7.47
- Resistance Level
- HNST $3.96
- LXEO $11.72
- Average True Range (ATR)
- HNST 0.36
- LXEO 0.91
- MACD
- HNST 0.32
- LXEO -0.13
- Stochastic Oscillator
- HNST 93.45
- LXEO 0.00
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.